Omnicell (OMCL) Common Equity (2010 - 2026)
Omnicell (OMCL) reported Common Equity of $1.29 billion for Q2 2026, up 2.2% from $1.26 billion a year earlier and up 2.8% from the prior quarter.
Powered by 
Analysis
Omnicell (OMCL) Common Equity (2010 - 2026) Analysis & Trends
At the end of FY2025, Omnicell posted Common Equity of $1.23 billion, down 0.9% from FY2024.
- Common Equity has a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
- By year, Common Equity came in at $1.24 billion in FY2024 (+4.6%), $1.19 billion in FY2023 (+5.2%), $1.13 billion in FY2022 (-1.4%) and $1.15 billion in FY2021 (+18.5%).
- The Q2 2026 figure ranks as the highest quarterly Common Equity in data going back to Q4 2010.
- Year over year, Common Equity gained in five of the last eight quarters, with growth averaging 2.4%.
- The high point for year-over-year Common Equity in five years was Q3 2021 (growth of 21.0%); the low point was Q4 2022 (a decline of 1.4%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.26 billion (Q1 2026), $1.23 billion (Q4 2025) and $1.22 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 250.84 Bn | 229.99 Bn | 4.88 Bn | 52.69 Bn |
| 2 | Abbott Laboratories | 174.73 Bn | 145.82 Bn | 7.27 Bn | 51.76 Bn |
| 3 | Danaher | 159.85 Bn | 143.67 Bn | 3.61 Bn | 52.59 Bn |
| 4 | Intuitive Surgical | 146.79 Bn | 126.35 Bn | 1.96 Bn | 18.30 Bn |
| 5 | Medtronic | 114.54 Bn | 80.41 Bn | 6.34 Bn | 50.85 Bn |
| 6 | Stryker | 105.67 Bn | 91.79 Bn | 4.50 Bn | 23.99 Bn |
| 7 | Boston Scientific | 63.93 Bn | 58.94 Bn | 3.85 Bn | 25.17 Bn |
| 8 | Becton Dickinson | 50.12 Bn | 47.27 Bn | 2.32 Bn | 24.42 Bn |
| 9 | Edwards Lifesciences | 50.06 Bn | 34.17 Bn | 1.35 Bn | 10.72 Bn |
| 10 | Omnicell | 1.54 Bn | 636.87 Mn | 152.94 Mn | 1.29 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.29 Bn |
| Mar 31, 2026 | 1.26 Bn |
| Dec 31, 2025 | 1.23 Bn |
| Sep 30, 2025 | 1.22 Bn |
| Jun 30, 2025 | 1.26 Bn |
| Mar 31, 2025 | 1.26 Bn |
| Dec 31, 2024 | 1.24 Bn |
| Sep 30, 2024 | 1.23 Bn |
| Jun 30, 2024 | 1.20 Bn |
| Mar 31, 2024 | 1.19 Bn |
| Dec 31, 2023 | 1.19 Bn |
| Sep 30, 2023 | 1.19 Bn |
| Jun 30, 2023 | 1.16 Bn |
| Mar 31, 2023 | 1.14 Bn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 1.14 Bn |
| Jun 30, 2022 | 1.09 Bn |
| Mar 31, 2022 | 1.07 Bn |
| Dec 31, 2021 | 1.15 Bn |
| Sep 30, 2021 | 1.11 Bn |
API Access
Omnicell Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=OMCL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "OMCL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=OMCL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();